Mesenchymal Stromal Cells therapy(Assistance Publique Hopitaux De Paris)

N/A

Report date: 2023/11/28 20:05:47

Base Information

Drug NameMesenchymal Stromal Cells therapy(Assistance Publique Hopitaux De Paris)
Drug Alias NameMesenchymal Stromal Cells (MSC)(Assistance Publique Hopitaux De Paris)Systemic Mesenchymal Stromal Cell (MSC) (Assistance Publique Hopitaux De Paris)
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsUndifferentiated Connective Tissue DiseasesScleroderma, SystemicCystitis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAssistance Publique Hopitaux De Paris
China Registration ClassN/A

Develop Information

Active CompaniesAssistance Publique Hopitaux De Paris
Inactive CompaniesN/A
Active IndicationsUndifferentiated Connective Tissue DiseasesScleroderma, SystemicBrain Injuries, Traumatic +[4] 
Inactive IndicationsCystitis

Other Information

ATC CodeN/A
Related LinksN/A